Torsades De Pointes
Drug labels, QT prolongation and ECG recommendations
CredibleMeds now includes information from FDA drug labels to inform prescribers of any ECG monitoring recommendations, warnings for use in congenital long QT and any contraindicated concomitant drugs.
Androgen-deprivation therapy yields risk for QT prolongation, torsades de pointes
Men receiving androgen-deprivation therapies for hypogonadism often had elevated risk for QT prolongation and torsades de pointes, which confer heightened sudden death odds, researchers reported in Circulation.
Part of the Healio Network
Polymorphic Ventricular Tachycardia (Torsades de Pointes)
Polymorphic ventricular tachycardia (a.k.a. Torsades de Pointes) is best treated with intravenous magnesium. Patients with a prolonged QT interval have a higher risk of developing polymorphic VT.
Part of the Healio Network
Long QT Syndrome
Prolonged QT syndrome (a.k.a. Long QT Syndrome) consists of multiple different variations including long QT type 1-12, Romano-Ward syndrome and Jervell-Lange-Nielsen syndrome.
Part of the Healio Network
Ibutilide Topic Review
Ibutilide is a class III antiarrhythmic drug and works via enhancement of the slow inward sodium current, unlike other class III agents that are cardiac potassium channel blockers.
Part of the Healio Network
QT Interval
The QT interval is the time from the beginning of the QRS complex (ventricular depolarization) to the end of the T wave (ventricular repolarization).